Related Experiment Video
Updated: Mar 28, 2026
05:18
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
2.0K
A Case of Nonuremic Calciphylaxis Treated Effectively With Systemic Corticosteroids
Ajoy Biswas1, Noreen M Walsh2, Robert Tremaine2
1Dalhousie University, Halifax, NS, Canada aj.biswas@dal.ca.
Journal of Cutaneous Medicine and Surgery
|December 25, 2015
Summary
Calciphylaxis, a rare condition causing arterial calcification and tissue death, can occur in patients with normal kidney function. This case report highlights successful treatment of nonuremic calciphylaxis using systemic corticosteroids.
Area of Science:
- Vascular Medicine
- Dermatology
- Nephrology
Background:
- Calciphylaxis is a severe systemic condition characterized by arterial calcification, leading to painful skin necrosis and high mortality.
- While often associated with end-stage renal disease, calciphylaxis can also manifest in individuals with preserved renal function.
- The underlying etiology remains unclear, and treatment options yield variable success rates.
Observation:
- This case report details a patient experiencing acute nonuremic calciphylaxis.
- The patient presented with symptoms indicative of calciphylaxis despite having normal kidney function.
Findings:
- The patient demonstrated a significant positive response to treatment with systemic corticosteroids.
- This suggests a potential therapeutic role for corticosteroids in nonuremic calciphylaxis.
Implications:
- These findings suggest that systemic corticosteroids may be an effective treatment modality for nonuremic calciphylaxis.
- Further research is warranted to explore the efficacy and safety of corticosteroids in managing this rare and devastating condition.
- This case broadens the understanding of calciphylaxis treatment possibilities beyond traditional approaches.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
624
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
624
01:26Nephrotic Syndrome II : Assessment and Medical Management
320
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
320
01:24Nephrotic Syndrome III : Nursing Management
438
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
438
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
664
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
664
01:24Nephrotic Syndrome I : Introduction
968
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
968
01:30Urinary Tract Calculi III: Medical Management
322
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
322